November 12, 2006 (Press Release) --
Based on scientific research suppressed by the U.S. Centers for Disease Control (CDC), this medical exposé identifies serious threats to public health posed by mass chickenpox vaccination, which the CDC recommended shortly after the Food and Drug Administration (FDA) approved the vaccine in March, 1995.
From 1995 through 2002, Gary S. Goldman, Ph.D., served as a research analyst for a CDC-funded study on the effects of universal varicella vaccination. He found preliminary evidence that the vaccine had the potential to spawn an epidemic far worse than the mild childhood illness against which millions were being inoculated.
The same virus that causes chickenpox (or varicella), also produces shingles, an excruciating neurological condition that can lead to debility and even death. The risk of complications from shingles increases with age and include hearing loss, blindness, facial paralysis, bladder impairment, and post-herpetic neuralgia (PHN), debilitating pain that persists long after the rash has subsided. Shingles accounts for about 75 percent of all medical costs resulting from the varicella-zoster virus. The incidence of the disease, especially among adults, is on the rise, as Goldman predicted. One CDC study has shown a 90% increase in adult shingles from 1998 to 2003, during a period of increasing chickenpox vaccination coverage. Further, the pharmaceutical giant Merck & Co. manufactures the varicella vaccine, which is now mandatory for school enrollment in a majority of states. Although it was initially thought that a single chickenpox shot was sufficient to induce long-term immunity, a booster chickenpox vaccine has recently been added to the childhood immunization schedule. Additionally, a shingles vaccine has been approved by the FDA in 2006 which will likely only serve to offset the increased incidence of shingles caused by the chickenpox vaccine.
From his research for the CDC-funded Varicella Active Surveillance Program (VASP) of Los Angeles County Department of Health Services, following a study population of 300,000, Goldman suspected that exposure to a child with chickenpox provided immunological “boosting” to help postpone or protect against shingles, a theory first proposed by Dr. R. Edgar Hope-Simpson in 1965. If this hypothesis were true, then the near-eradication of childhood chickenpox in response to universal varicella vaccination would dramatically increase the incidence of shingles. From 2000 to 2002, Goldman found the highest incidence rate of shingles ever reported among unvaccinated children with a previous history of natural chickenpox in the study community. Goldman also reported a statistically significant increase in shingles among adults in the study community.
But his superiors at the CDC didn’t want to hear about it; neither did Merck & Co. seem to express much interest. When Goldman tried to alert them that universal varicella vaccination could trigger a shingles epidemic, the public health officials seemingly dismissed and later criticized his claim. On grounds of conscience and because he was prevented from conducting objective research, Goldman resigned from the program in 2002. When he independently submitted his findings to a peer-reviewed scientific journal, VASP’s attorney ordered him to “cease and desist.”
Goldman did not cease and desist in his mission to raise public awareness and to call for accountability in the medical research establishment. Since 2004, Goldman has served as Editor-in-Chief of Medical Veritas: The Journal of Medical Truth. He has authored articles on varicella vaccination and shingles incidence in the peer-reviewed journals Vaccine, International Journal of Toxicology, Pediatrics, and the Journal of the American Medical Association.
In the same vein as David Kirby’s best-selling Evidence of Harm but based on the painstaking research of a true insider, The Chickenpox Vaccine exposes the ills, both social and medical, that occur when profits are put above the public health. If we follow Goldman’s lead, it’s not too late to heal this breach in public trust and the expensive disease and treatment cycles this has spawned.
From 1995 through 2002, Gary S. Goldman, Ph.D., served as a research analyst for a CDC-funded study on the effects of universal varicella vaccination. He found preliminary evidence that the vaccine had the potential to spawn an epidemic far worse than the mild childhood illness against which millions were being inoculated.
The same virus that causes chickenpox (or varicella), also produces shingles, an excruciating neurological condition that can lead to debility and even death. The risk of complications from shingles increases with age and include hearing loss, blindness, facial paralysis, bladder impairment, and post-herpetic neuralgia (PHN), debilitating pain that persists long after the rash has subsided. Shingles accounts for about 75 percent of all medical costs resulting from the varicella-zoster virus. The incidence of the disease, especially among adults, is on the rise, as Goldman predicted. One CDC study has shown a 90% increase in adult shingles from 1998 to 2003, during a period of increasing chickenpox vaccination coverage. Further, the pharmaceutical giant Merck & Co. manufactures the varicella vaccine, which is now mandatory for school enrollment in a majority of states. Although it was initially thought that a single chickenpox shot was sufficient to induce long-term immunity, a booster chickenpox vaccine has recently been added to the childhood immunization schedule. Additionally, a shingles vaccine has been approved by the FDA in 2006 which will likely only serve to offset the increased incidence of shingles caused by the chickenpox vaccine.
From his research for the CDC-funded Varicella Active Surveillance Program (VASP) of Los Angeles County Department of Health Services, following a study population of 300,000, Goldman suspected that exposure to a child with chickenpox provided immunological “boosting” to help postpone or protect against shingles, a theory first proposed by Dr. R. Edgar Hope-Simpson in 1965. If this hypothesis were true, then the near-eradication of childhood chickenpox in response to universal varicella vaccination would dramatically increase the incidence of shingles. From 2000 to 2002, Goldman found the highest incidence rate of shingles ever reported among unvaccinated children with a previous history of natural chickenpox in the study community. Goldman also reported a statistically significant increase in shingles among adults in the study community.
But his superiors at the CDC didn’t want to hear about it; neither did Merck & Co. seem to express much interest. When Goldman tried to alert them that universal varicella vaccination could trigger a shingles epidemic, the public health officials seemingly dismissed and later criticized his claim. On grounds of conscience and because he was prevented from conducting objective research, Goldman resigned from the program in 2002. When he independently submitted his findings to a peer-reviewed scientific journal, VASP’s attorney ordered him to “cease and desist.”
Goldman did not cease and desist in his mission to raise public awareness and to call for accountability in the medical research establishment. Since 2004, Goldman has served as Editor-in-Chief of Medical Veritas: The Journal of Medical Truth. He has authored articles on varicella vaccination and shingles incidence in the peer-reviewed journals Vaccine, International Journal of Toxicology, Pediatrics, and the Journal of the American Medical Association.
In the same vein as David Kirby’s best-selling Evidence of Harm but based on the painstaking research of a true insider, The Chickenpox Vaccine exposes the ills, both social and medical, that occur when profits are put above the public health. If we follow Goldman’s lead, it’s not too late to heal this breach in public trust and the expensive disease and treatment cycles this has spawned.

Gary S. Goldman, Ph.D., reveals the serious threat to public health posed by varicella vaccination—-and attempts by the healthcare establishment and pharmaceutical industry to cover it up.

Email
Print
Download
SPAM
LEAVE A COMMENT



